Comments regarding use of rifabutin for eradication

Guardado en:

Detalles Bibliográficos
Autor principal:	David Y. Graham
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/ad35d34d53aa4a0db4cb80d01f229922
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ad35d34d53aa4a0db4cb80d01f229922
record_format	dspace
spelling	oai:doaj.org-article:ad35d34d53aa4a0db4cb80d01f2299222021-11-05T12:03:20ZComments regarding use of rifabutin for eradication1756-284810.1177/17562848211044064https://doaj.org/article/ad35d34d53aa4a0db4cb80d01f2299222021-10-01T00:00:00Zhttps://doi.org/10.1177/17562848211044064https://doaj.org/toc/1756-2848David Y. GrahamSAGE PublishingarticleDiseases of the digestive system. GastroenterologyRC799-869ENTherapeutic Advances in Gastroenterology, Vol 14 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the digestive system. Gastroenterology RC799-869
spellingShingle	Diseases of the digestive system. Gastroenterology RC799-869 David Y. Graham Comments regarding use of rifabutin for eradication
format	article
author	David Y. Graham
author_facet	David Y. Graham
author_sort	David Y. Graham
title	Comments regarding use of rifabutin for eradication
title_short	Comments regarding use of rifabutin for eradication
title_full	Comments regarding use of rifabutin for eradication
title_fullStr	Comments regarding use of rifabutin for eradication
title_full_unstemmed	Comments regarding use of rifabutin for eradication
title_sort	comments regarding use of rifabutin for eradication
publisher	SAGE Publishing
publishDate	2021
url	https://doaj.org/article/ad35d34d53aa4a0db4cb80d01f229922
work_keys_str_mv	AT davidygraham commentsregardinguseofrifabutinforeradication
_version_	1718444309262368768

Ejemplares similares